I couldn't even see a mention of the recent DEP® Research Agreement with Genentech in today's newsletter either ?
I did however raise my concerns re: India this morning in this post below .... > 6 months since registration approval in India with no distribution agreement for Viraleze in the middle of a pandemic .... something smells
https://hotcopper.com.au/threads/new-africa-variant.6448058/page-48?post_id=58326167#.YbrGHWhBzIU
The fact remains @stoway they can say in their marketing that they have done a human trial regardless if it is flawed ….. so can SaNOtize who are running a subsequent trial in guess where - India
https://www.biospace.com/article/re...notize-s-breakthrough-treatment-for-covid-19/
There is some reason the India registration has gone nowhere in 6 months … what could it be ?
Ann: Shareholder Newsletter, page-6
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.8¢ |
Change
-0.002(2.00%) |
Mkt cap ! $40.97M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.0¢ | 9.8¢ | $39.64K | 402.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 824859 | 9.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 221589 | 7 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |